Back to Agenda
Break Out Sessions 1A: Decentralised Clinical Trials
Session Chair(s)
Elke Stahl, PHD
Senior Expert, Clinical Trials Department, Federal Institute For Drugs and Medical Devices (BfArM), Germany
Speaker(s)
Karen A Noonan, MA
Senior Vice President, Global Regulatory Policy, Association of Clinical Research Organizations (ACRO), United States
The Unique Power of Planned DCTs
Bhausaheb S. Patil, MPHARM
Head Business Operations - Decentralized Clinical Trials, IQVIA, United Kingdom
Measuring Success of DCTs
Amos De Jong, MSC
PhD candidate, Utrecht University, Netherlands
Regulatory views on trials @ home – the proof of the pudding is in the eating
Mira Zuidgeest, PHARMD, PHD, MSC
Associate Professor, University Medical Center Utrecht, Netherlands
Learnings from IMI Trials@Home
Monique Al, PHD
Special advisor CCMO, Central Committee on Research Involving Human Subjects (CCMO), Netherlands
DCT Recommendation Paper – Update
Greet Musch, PHD
strategic adviser , FAMHP, Belgium
Panel discussion with Q&A, with participation:
Have an account?